Greenyard to report first half year results 2018/2019 (19.11.2018) | Vlaamse Federatie van Beleggers

In addition to the acquisition of a German healthcare portfolio of 17 nursing and care homes valued at more than 170 million EUR in June 2018, Cofinimmo made several other deals

• 38.1% in the fourth quarter 2018, compared to 31.8% a year ago, due to the increase in the effective tax rate for Exploration & Production in line with higher

Net interest expense and other financing costs for the year ended December 31, 2018 were EUR (6) million, including cash cost of financing of EUR (9) million, including an

 In March 2018, Mithra announced it had granted an exclusive license and supply agreement to Alvogen for the commercialization of Myring™ in Russia, a market worth approximately EUR

 Lower Proton Therapy sales in 2018 compared to 2017, reflecting the fact that of the seven rooms sold (five sold in 2017), only three were financially activated at the year

• 14 June 2018: In conjunction with the merger with Gener8, Euronav sold six VLCCs to International Seaways for a total consideration of USD 434 million which included USD

ASIT biotech’s product pipeline contains three novel ASIT+™ product candidates targeting respiratory allergies with the highest prevalence (i.e. grass pollen: gp-ASIT+™ - in

This increase mainly results from the net proceeds of two share offerings for a total amount of EUR 50.6 million and net proceeds drawn on a new debt facility agreement (EUR